Interaction of clozapine with metformin in a schizophrenia rat model
Abstract The low efficacy of antipsychotic drugs (e.g., clozapine) for negative symptoms and cognitive impairment has led to the introduction of adjuvant therapies. Because previous data suggest the procognitive potential of the antidiabetic drug metformin, this study aimed to assess the effects of...
Enregistré dans:
Auteurs principaux: | G. Horvath, G. Kis, G. Kekesi, A. Büki, L. G. Adlan, E. Szűcs, H. El Heni, S. Benyhe |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/2d9dba62c9c244dd8d679eb05da2ea09 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Clinical predictors of response to clozapine in Tunisian patients with treatment resistant schizophrenia
par: Amina Aissa, et autres
Publié: (2022) -
The effectiveness of non-clozapine antipsychotics combined with electroconvulsive therapy versus clozapine combined with electroconvulsive therapy for treatment-resistant schizophrenia
par: Pichai Ittasakul, et autres
Publié: (2021) -
Use of clozapine in older Asian patients with schizophrenia between 2001 and 2009.
par: Yu-Tao Xiang, et autres
Publié: (2013) -
Managing Recurrent Clozapine-Induced Constipation in a Patient with Resistant Schizophrenia
par: Silviu Tomulescu, et autres
Publié: (2021) -
Clozapine Management in Schizophrenia Inpatients: A 5-Year Prospective Observational Study of Its Safety and Tolerability Profile
par: de Filippis R, et autres
Publié: (2021)